Detalhe da pesquisa
1.
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.
Eur J Haematol
; 111(3): 365-372, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254665
2.
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis.
Ann Hematol
; 101(8): 1719-1726, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732976
3.
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
Ann Hematol
; 101(9): 2001-2010, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35739428
4.
Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3-ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission.
Eur J Haematol
; 106(1): 64-71, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949053
5.
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
Am J Hematol
; 96(7): 790-795, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836555
6.
How we treat older patients with acute myeloid leukaemia.
Br J Haematol
; 191(5): 682-691, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32352169
7.
Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort Study.
Clin Infect Dis
; 69(10): 1805-1808, 2019 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30855077
8.
How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia.
Haematologica
; 104(11): 2135-2143, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582548
9.
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.
Ann Hematol
; 98(12): 2711-2717, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512015
10.
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a realworld, multicenter, matched analysis.
Ann Hematol
; 101(9): 2011, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869985
11.
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.
Am J Hematol
; 95(1): E3-E5, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591736
12.
Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study.
Leuk Res
; 119: 106902, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777176
13.
Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effect.
Am J Health Syst Pharm
; 78(9): 794-799, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617629
14.
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia.
Leukemia
; 34(1): 293-295, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31435023